Despite the growth in the availability and complexity of biochemical tests in recent years, they have been used largely to establish a diagnosis in living patients. We report a case in which a biochemical test performed on blood collected post mortem not only helped to establish a diagnosis in the index case but also had profound implications for surviving family members.
Case report
A 26 year old lean, muscular man collapsed while jogging and died despite attempts at resuscitation. He had jogged and played squash regularly and had not suffered any recent illnesses. He had consulted his general practitioner a year before his death complaining of chest pain, which was attributed to bruised ribs.
A 
Comment
Our patient was probably suffering from heterozygous familial hypercholesterolaemia. This is perhaps the most common single gene disorder affecting man, with a heterozygote prevalence of about one in 500.3 It is inherited in an autosomal dominant fashion, and its principal features are premature ischaemic heart disease and considerable hypercholesterolaemia. Recent evidence suggests that energetic methods of reducing blood cholesterol concentrations result in a reduced risk of coronary heart disease, but efforts to screen close relatives of patients with hypercholesterolaemia are currently neglected.4 The importance of identifying subjects at risk from coronary heart disease is emphasised by the growing number of reports of sudden death during exercise.5
Cholesterol concentrations in blood collected post mortem are a valid reflection of antemortem concentrations, and their measurement is indicated in cases of premature, sudden death from coronary heart disease, which is often associated with exercise. When short and long acting insulins are mixed in one syringe before administration it is of crucial importance that the initial rapid absorption of the regular component is preserved.
In the present study we investigated absorption kinetics and bioavailability of subcutaneously injected regular insulin mixed with Ultratard HM or Ultratard MC.
Subjects, methods, and results
Sixteen men of normal weight were assigned to receive either human or bovine ultralente insulin. Each proband was subjected to three different tests carried out in randomised order after an overnight fast of 14 hours: (1) 10 U Actrapid HM and 16 U Ultratard HM, or 10 U Actrapid MC and 16 U Ultratard MC, were injected simultaneously into contralateral thighs; (2) the same insulins in identical ratios were injected immediately after mixing in one syringe; and (3) the same insulins in identical ratios were injected five minutes after mixing. Throughout the tests the probands rested supine and abstained from food and drink. At the time points indicated in the figure venous blood was taken for determination of plasma glucose, serum insulin, and plasma C peptide concentrations using methods described previously.4 Serum insulin concentrations were measured only in the study of human ultralente insulin. Data are given as means (SEM) . Insulin values are expressed as the increase above basal concentrations. Student's t test for paired comparisons was used to evaluate the significance of the differences between the results of the tests in the same subjects; p <0Q05 indicated significance.
In the study of Ultratard HM basal insulin concentrations (mean of two measurements) were 10-9 (1-5) mU/l (test 1), 7-3 (1.0) mU/l (test 2), and 6-9 (10) mU/l (test 3). The increase in serum insulin concentration was significantly higher in test 1 than in tests 2 and 3 throughout the study and significantly higher in test 2 than test 3 at 30 and 40 minutes (figure). These differences in the behaviour of serum insulin concentrations were inversely reflected in blood glucose and C peptide concentrations (C peptide concentrations indicating suppression of endogenous insulin).
In the study of Ultratard MC we did not observe any difference in the behaviour of blood glucose and C peptide concentrations between tests 1 and 2, but blood glucose concentrations remained significantly higher in test 3 than in test 1. Accordingly, C peptide concentrations were significantly higher in test 3 than in test 1 between 30 and 50 minutes after injection.
